Close
Search
Close

Konstantin Sharlovskiy is heading Pepeliaev Group’s life sciences practice

29.04.2021
Pepeliaev Group's team has been joined by Konstantin Sharlovskiy, who, as the head of the life sciences practice, will be providing legal support to clients on different matters connected with the circulation of medicines, medical products and other types of pharmaceuticals, as well as on other legal matters that are specific to the areas of pharmaceuticals and healthcare.

Konstantin has been providing assistance to pharmaceutical companies in Russia and the CIS for more than 8 years. He specialises in transactions with assets in the area of pharmaceuticals, solving complex regulatory issues, including those connected with intellectual property, the localisation of manufacturing in Russia and with advertising and other methods of promoting pharmaceutical products. Konstantin has vast experience of representing clients in negotiations, and within the framework of complaint proceedings and in litigation, including disputes with supervisory authorities.

Pepeliaev Group's life sciences practice provides comprehensive legal support on regulatory matters in the pharmaceutical industry, on the circulation of medical devices and other topical issues of commercial law, corporate law and other branches. Our clients are major Russian and international companies, as well as start-ups in the fields of healthcare and pharmaceuticals.

Konstantin will continue to develop the life sciences practice with active support from Pepeliaev Group partners Ilya Bolotnov and Maria Nikonova, who have many years of experience in providing assistance to clients, including in the areas of pharmaceuticals and healthcare. 

Back to the list

01.10.2021
Konstantin Sharlovskiy spoke at the ‘Medicines of Russia - to an interdisciplinary dialogue’ Partnership Forum
Read more
19.08.2021
Pepeliaev Group is strengthening its judicial practice in the area of corporate disputes
Read more
02.08.2021
Advertising on the Internet Will Be Recorded
Read more

Вход | Регистрация

E-mail

Click here to subscribe our English newsletters